BioIVT, formerly BioreclamationIVT, is a leading global provider of high-quality biological specimens and value-added services. We specialize in control and disease state samples including human and animal tissues, cell products, blood and other biofluids. Our unmatched portfolio of clinical specimens directly supports precision medicine research and the effort to improve patient outcomes by coupling comprehensive clinical data with donor samples.
Our PHASEZERO® Research Services team works collaboratively with clients to provide target and biomarker validation, phenotypic assays to characterize novel therapeutics, clinical assay development and in vitro hepatic modeling solutions. And as the world’s premier supplier of ADME-Tox model systems, including hepatocytes and subcellular fractions, BioIVT enables scientists to better understand the pharmacokinetics and drug metabolism of newly discovered compounds and the effects on disease processes. By combining our technical expertise, exceptional customer service, and unparalleled access to biological specimens, BioIVT serves the research community as a trusted partner in ELEVATING SCIENCE®.
The list of companies have been acquired by BioIVT. The BioIVT brand will replace the brand of each of the affiliates and subsidiaries listed below:
- Celsis IVT
- Sera Laboratories International
- TransCell Science
- Asterand Bioscience
- Qualyst Transporter Solutions
- Ascendance Biotechnology
- Optivia Biotechnology
- Clinical Trials Laboratory Services (CTLS)
- Biological Specialty Corporation (BSC)
Click here if you require more information or documentation for our 2018 rebrand along with a listing of recently acquired BioIVT affiliate companies.